General Experimental and Materials
All reactions were carried out in oven-dried glassware under an atmosphere of nitrogen using standard anhydrous techniques. All reagents were obtained from commercially available sources and used without further purification, or where indicated prepared internally. Air-and moisturesensitive liquids and solutions were transferred via syringe or stainless steel cannula. Reactions performed at 0 °C were done so using an ice bath. Anhydrous dichloromethane and tetrahydrofuran were obtained by distillation from calcium hydride, and sodium wire with a benzophenone indicator, respectively. Other anhydrous reaction solvents were obtained from standard anhydrous solvent engineering system. Petrol (or PE) refers to the fraction of light petroleum ether boiling between 40 and 65 °C. Triethylamine was stored over potassium hydroxide. All products were dried on a rotary evaporator followed by connection to a high vacuum system to remove any residual solvent. Flash chromatography was performed on silica gel (Merck 60H, . Analytical thin layer chromatography was performed on aluminium backed silica (60 F254) plates.
Instrumentation
All 1 H and 13 C nuclear magnetic resonance spectra were obtained using Bruker AVANCE 400, 500 or 800 MHz spectrometers. Chemical shifts are quoted in parts per million (ppm), and coupling constants (J) are quoted in Hz to the nearest 0.5 Hz. 1 H-NMR spectra were referenced to the residual deuterated solvent peak (CDCl3 7.27; CD3OD 3.31; THF-d8 1.73 ppm) and 13 C-NMR were referenced to the carbon resonance of the solvent (CDCl3 77.00; CD3OD 49.05; THF-d8 25.37 ppm). Multiplicities are denoted as s (singlet), d (doublet), t (triplet), q (quartet), spt (septet) and m (multiplet) or denoted as br (broad), or some combination of these, where appropriate. Where 1 H-NMR spectra were run in CD3OD exchangeable protons (NH, OH) are reported only where observed. Assignments were made using DEPT-135, 2D 1 H-COSY and HMQC experiments.
Infra-red spectra were recorded on an ATi Perkin Elmer Spectrum RX1 FT-IR spectrometer. Only absorption maxima (λmax) of interest are reported and quoted in wavenumbers (cm -1 ). Low and high resolution mass spectra were recorded by staff at the University of Manchester. Electrospray (ES) spectra were recorded on a Waters Platform II and high resolution mass spectra (HRMS) were recorded on a Thermo Finnigan MAT95XP and are accurate to ±0.001 Da. Melting points were determined on a GallenKamp apparatus and are uncorrected. Optical rotation measurements were taken on an AA-100 polarimeter at 20 °C with the solvent and concentration (g/100 mL) stated. Circular Dichroism (CD) measurements were performed at 20 °C on a JASCO J-815 spectropolarimeter, using a 1 mm cell with the solvent and concentration stated, where applicable. Analytical HPLC analysis was performed on a Hewlett-Packard series 1050 system, using the column and eluent stated, with UV detection at 254, 230 and 210 nm.
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Experimental Procedures
Methods for the synthesis of N3Aib4OH, HAib4OtBu, Z-GlyAib4O t Bu, 1 Z-Aib*Aib4OH and Z-L-AlaNH t Bu 2 have been previously reported.
Abbreviations DIPEA, N,N-diisopropylethylamine; EDC, N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide; HOAt, 1-Hydroxy-7-azabenzotriazole; HOBt, 1-hydroxybenzotriazole; IBCF, isobutyl chloroformate; NMM, 4methylmorpholine; Z, carboxybenzyl.
5-Bromo-7-nitroindoline (Bni) 1
5-Bromo-7-nitroindoline 1 was prepared according to the method reported by Hiroshi et al.. 3 The pure product (757 mg, 89%) was isolated as an orange solid by column chromatography (4:1 PE:EtOAc). 1 H-NMR (400 MHz, CDCl3) δH 7.95 (1H, m, o-NO2-ArCH), 7.28 (1H, m, p-NO2-ArCH), 6.80 (1H, br s, NH), 3.91 (2H, m, CH2-NH), 3.20 (2H, m, . 13 C-NMR (101 MHz, CDCl3) δC 148.1 (ArC), 136.0 (ArC), 132.6 (p-NO2-ArCH), 129.1 (ArC), 124.4 (o-NO2-ArCH), 107.1 (ArC), 46.9 (CH2-NH), 28.0 (CH2-Ar). IR (neat) max/cm -1 = 3377, 3088, 2890, 2362, 1624, 1585, 1508, 1485, 1434, 1412 Fmoc-L-AlaBni 1 (243 mg, 1 mmol) and Fmoc-L-Ala-OH (311 mg, 1 mmol) were dissolved in toluene and thionyl chloride (0.15 mL, 2 mmol) was added dropwise and the reaction stirred at 70 °C for 16 h. EtOAc (20 mL) was added and the organic phase washed with HCl (1 M, 2 x 10 mL), NaHCO3 (sat., 2 x 10 mL), brine (10 mL), dried (MgSO4), filtered and concentrated. The crude residue was purified by column chromatography (1:9 to 1:1 EtOAc:PE) to give the pure product (463 mg, 86%) as a yellow solid. 1 H-NMR (400 MHz, CDCl3) δH 7.84 (1H, s, o-NO2-ArCH), 7.76 (2H, d, J=7.5, ArCH x2 (Fmoc)), 7.58 (3H, m, p-NO2-ArCH and ArCH x2 (Fmoc)), 7.40 (2H, ddd, J 7.5, 7.5, 2.5, ArCH x2 (Fmoc)), 7.31 (2H, m, ArCH x2 (Fmoc)), 5.61 (1H, d, J=8.0, NH), 4.74 (1H, dq, J= 7.0, 7.0, CH-CH3), 4.58 (1H, ddd, J 10.0, 10.0, 3.5, CH2-CH2N), 4.38 (1H, dd, J=10.5, 7.5 , H A of ABX system, CH2-CH), 4.34 (1H, dd, J=10.5, 7.5 , H B of ABX system, CH2-CH), 4.22 (2H, m, CH-CH2 and CH2N), 3.38 (1H, ddd, J=17.5, 9.5, 9.5 , CH2-Ar), 3.18 (1H, ddd, 16.5, 9.5, 3.5 , CH2-Ar), 1.50 (3H, d, J=7.0, CH3). 13 C-NMR (101 MHz, CDCl3) δC 171.6 (CO), 155.9 (CO (Fmoc)), 143.7 (ArC), 141.2 (ArC), 140.8 (ArC), 138.7 (ArC), 133.8 (ArC), 131.9 (p-NO2-ArCH), 127.7 (ArCH (Fmoc)), 127.1 (ArCH (Fmoc)), 125.5 (o-NO2-ArCH), 125.1 (ArCH (Fmoc)), 120.0 (ArCH S4 (Fmoc)), 117.0 (ArC), 67.2 (CH2-CH), 49.8 (CH2N), 49.1 (CH-CH3), 47.0 (CH-CH2), 29.1 (CH2Ar), 18.3 (CH3). IR (neat) max/cm -1 = 3312, 2951, 2360, 2341, 1679, 1537, 1460, 1450 
H-L-AlaBni 2
Fmoc-L-AlaBni (391 mg, 0.73 mmol) was dissolved in CH2Cl2 (4 mL) and diethylamine (1 mL) was added. The solution was stirred for 5 h and then concentrated. The crude residue was purified by column chromatography (2-10% MeOH in CH2Cl2) to give the pure product (236 mg, 91%) as a yellow waxy solid. 1 H-NMR (400 MHz, CDCl3) δH 7.80 (1H, s, o-NO2-ArCH), 7.56 (1H, s, p-NO2-ArCH), 4.37 (1H, ddd, J 10.0, 10.0, 5.0, CH2N), 4.20 (1H, m, CH2N), 3.84 (1H, q, J=7.0, CH-CH3), 3.32 (1H, ddd, J 17.5, 9.0, 9.0, CH2Ar), 3.18 (1H, ddd, J=9.5, 9.5, 5. 
Z-L-Phe-L-AlaBni
Z-L-PheOH (45 mg, 0.15 mmol) and HOBt hydrate (28 mg, 0.16 mmol) were dissolved in CH2Cl2 (5 mL) . EDC hydrochloride (161 mg, 0.84 mmol) and DIPEA (44 L, 0.25 mmol) were added and the reaction mixture stirred until it was homogenous. Then, 2 (31 mg, 0.1 mmol) was added and the reaction mixture was stirred for 48 h. EtOAc (10 mL) was added and the organic phase washed with KHSO4 (5%, 2 x 5 mL), NaHCO3 (sat., 2 x 5 mL), brine (5 mL), dried (MgSO4), filtered and concentrated. The crude residue was purified by column chromatography (1:3 to 1:0 EtOAc:PE) to give the pure product (41 mg, 71%) as a yellow solid. 1 H-NMR (400 MHz, CDCl3) δH 7.83 (1H, s, o-NO2-ArCH), 7.58 (1H, s, p-NO2-ArCH), 7.14 -7.34 (10H, m, ArCH x10), 6.75 (1H, br d, J=6.5, NH(Ala)), 5.16 (1H, br d, J=7.5, NH (Phe)), 5.04 (2H, s, CH2O), 4.89 (1H, dq, J=7.0, 7.0, CH-CH3), 4.51 (1H, ddd, J=10.0, 10.0, 3.5, CH2N), 4.46 (1H, br dd, J=7.0, 7.0, CH-CH2), 4.18 (1H, ddd, J=9.5, 9.5, 9.5, CH2N) , 3.34 (1H, m, CH2Ar), 3.15 (1H, ddd, J=9.5, 9.5, 4 .0, CH2Ar), 3.08 (2H, d, J=6.0, CH2-CH (Phe)), 1.40 (3H, d, J=6.5, CH3) . 13 C-NMR (101 MHz, CDCl3) δC 170.82 (CO), 170.75 (CO), 155.8 (CO (Cbz)), 140.8 (ArC), 138.9 (ArC), 136.0 (ArC), 135.9 (ArC), 133.8 (ArC), 131.9 (p-NO2-ArCH), 129.3 (ArCH), 128.7 (ArCH), 128.5 (ArCH), 128.2 (ArCH), 128.0 (ArCH), 127.1 (ArCH), 125.4 (o-NO2-ArCH), 116.9 (ArC), 67.1 (CH2O), 55.8 (CH-CH2 (Phe)), 49.8 (CH2N), 47.5 (CH-CH3 (Ala)), 38.0 (CH2-CH (Phe)), 29.1 (CH2Ar), 17.8 (CH3). IR (neat) max/cm -1 = 3304, 3064, 2360, 1683, 1638, 1563, 1535, 1497, 1459 
Z-(R)-Aib*-Aib4-L-AlaBni 4
Z-(R)-Aib*-Aib4-OH 3 (15 mg, 0.026 mmol) and HOBt hydrate (6 mg, 0.034 mmol) were dissolved in CH2Cl2 (2 mL). EDC hydrochloride (5.5 mg, 0.029 mmol) and triethylamine (9 L, 0.065 mmol) were added and the reaction mixture stirred until it was homogenous. Then, 2 (20 mg, 0.065 mmol) was added and the reaction mixture was stirred for 48 h. EtOAc (10 mL) was added and the organic phase washed with KHSO4 (5%, 2 x 3 mL), NaHCO3 (sat., 2 x 3 mL), brine (3 mL), dried (MgSO4), filtered and concentrated. The crude residue was purified by column chromatography (0.5-5% MeOH in CH2Cl2) to give the pure peptide (13 mg, 57%) as a yellow solid. 4.19 (1H, ddd, J=9.5, 9.5, 9.5, CH2N) 
Z-Aib*-Aib4-L-AlaNH i Pr 5
Z-Aib*-Aib4-L-AlaBni 4 (6.5 mg, 0.0074 mmol) and i PrNH2 (3.2 L, 0.037 mmol) were dissolved in THF-d8 (1.5 mL) and the solution irradiated at 360 nm (Atlas Photonics LUMOS 43 UV-LED) for 1 h. The solution was concentrated in vacuo and the crude residue purified by column chromatography (1-5% MeOH in CH2Cl2) to give the pure peptide (5 mg, 97%) as a white solid. J=4.0, CH3 major), 1.39 (0.7H, d, J=129.0, *CH3 minor), 1.36 (3H, d, J=7.5, CH3-CH), 1.25 (3H, s, CH3), 1.13 (3H, d, J= 6.5, CH3-CH), 1.11 (3H, d, J=6.5, . 13 C-NMR (101 MHz, THF-d8) δC 176.6 (CO), 176.34 (CO), 176.26 (CO), 175.9 (CO), 174.7 (CO), 172.3 (CO), 157.6 (CO (Cbz)), 138.2 (ArC), 129.5 (ArCH), 129.14 (ArCH), 129.07 (ArCH), 67.6 (CH2O), 57.8 (  C), 57.7 (  C), 57.59 (  C), 57.57 (d, J=38.5,  C-*CH3), 57.5 (  C), 50.6 (  CH), 41.8 (CH), 28.2 (CH3), 27.6 (CH3), 27.4 (CH3), 27.2 (CH3), 26.6 (*CH3 minor), 24.1 (*CH3 major), 23.9 (CH3), 23.8 (CH3), 23.5 (CH3), 23.3 (CH3), 23.2 (CH3-CH), 22.8 (CH3-CH), 17.9 (CH3-CH(Ala)). IR (neat) max/cm -1 = 3298, 2982, 2937, 1703, 1651, 1528, 1455 
Z-L-Ala-NH-(CH2)2-N((CH2)2NHBoc)2
Di-tert-butyl(((2-aminoethyl)azanediyl)bis(ethane-2,1-diyl))dicarbamate was prepared according to a modified procedure by Ramdahl. 4 Di-tert-butyl dicarbonate (469 mg, 2.15 mmol) in CH2Cl2 (1 mL) was added dropwise to a solution of imidazole in CH2Cl2 (1 mL) and the resulting solution stirred for 1 h. This solution was then washed with H2O (2 x 2 mL) and the organic phase dried (Na2SO4), filtered and concentrated. The resulting residue was dissolved in toluene (1 mL) with tris(2aminoethyl)amine 6 (0.15 mL, 1 mmol) and the solution heated to 60 °C for 2.5 h. After cooling to room temperature, the toluene was removed in vacuo and CH2Cl2 (10 mL) was added. The organic phase was washed with H2O (4 x 5 mL) and was then dried (Na2SO4), filtered and concentrated to give the crude amine (244 mg, 70%). A portion of this (94 mg, 0.27 mmol) was then dissolved with Z-L-Ala-OH (56 mg, 0.25 mmol), EDC hydrochloride (48 mg, 0.25 mmol), HOAt hydrate (34 mg, 0.25 mmol) and NMM (82 L, 0.75 mmol) in CH2Cl2 (2 mL) and the resulting mixture stirred for 16 h. EtOAc (9 mL) was added and the organic phase washed with H2O (2 x 3 mL), NaHCO3 (sat., 2 x 3 mL), NH4Cl (sat., 2 x 3 mL), brine (3 mL), dried (Na2SO4), filtered and concentrated. The crude residue was purified by column chromatography (1-5% MeOH in CH2Cl2) to give the pure product (108 mg, 78%) as a colourless oil. 
Z-(R)-Aib*-Aib4-L-AlaNH-(CH2)2-N((CH2)2NHBoc)2
Z-(R)-Aib*-Aib4-OH 3 (97 mg, 0.17 mmol) and HOBt hydrate (38 mg, 0.22 mmol) were dissolved in CH2Cl2 (5 mL) . EDC hydrochloride (35 mg, 0.19 mmol) and triethylamine (60 L, 0.42 mmol) were added and the reaction mixture stirred until it was homogenous. Then, 7 (prepared by the quantitative hydrogenation of Z-L-Ala-NH-(CH2)2-N((CH2)2NHBoc)2, 79 mg, 0.19 mmol) was added and the reaction mixture was stirred for 48 h. CH2Cl2 (10 mL) was added and the organic phase washed with KHSO4 (5%, 2 x 3 mL), NaHCO3 (sat., 2 x 3 mL), brine (3 mL), dried (Na2SO4), filtered and concentrated. The crude residue was purified by column chromatography (1-8% MeOH in CH2Cl2) to give the pure peptide (153 mg, 92%) as a white solid. 
Z-(R)-Aib*-Aib4-L-AlaNH-(CH2)2-N((CH2)2NH2)2 8
Z-(R)-Aib*-Aib4-L-AlaNH-(CH2)2-N((CH2)2NHBoc)2 (145 mg, 0.15 mmol) was dissolved in CH2Cl2 (5 mL), then HCl (2 M in Et2O, 3 mmol) was added dropwise and the resulting solution stirred for 24 h. The solvent was removed in vacuo and Et2O was then added. This process was repeated twice more and the resulting precipitate was filtered and dried in vacuo. The hydrochloride salts were converted to the free amines by addition of NaHCO3 (sat., 5 mL) and extraction with CHCl3:IPA (3:1, 2 x 10 mL), giving the pure peptide (118 mg, 94%) as a white solid. of CH2-NH, CH2-NH2 x2 and CH2-N x3), 1.52 (3H, s, CH3), 1.50 (3H, s, CH3), 1.49 (3H, s, CH3), 1.48 (3H, m, CH3-CH), 1.45 (3H, s, CH3), 1.44 (0.8H, d, J=3.5, CH3 minor), 1.44 (2.2H, d, J=128 .0, *CH3 major), 1.40 (0.8H, d, J=129.0, *CH3 minor), 1.40 (2.2H, m, CH3 major), 1.39 (3H, s, CH3), 1.37 (3H, s, CH3), 1.35 (3H, s, CH3), 1.28 (3H, s, CH3) . 13 C-NMR (101 MHz, CD3OD) δC 178.6 (CO), 178.4 (CO), 178.1 (CO), 177.3 (CO), 177.1 (CO), 176.6 (CO), 158.0 (CO (Cbz)), 138.7 (ArC), 129.6 (ArCH), 129.0 (ArCH), 128.5 (ArCH), 67.6 (CH2O), 57.9 (  C), 57.7 (  C), 57.6 (d, J=39.0,  C-*CH3), 57.6 (  C), 57.5 (  C), 54.5 (CH2N), 52.5 (CH2N), 51.8 (CH), 36.9 (CH2N), 27.4 (CH3), 26.9 (CH3), 26.7 (CH3), 26.6 (CH3), 26.1 (*CH3 minor), 25.2 (CH3), 24.4 (*CH3 major), 23.7 (CH3), 23.7 (CH3 x2), 17.2 (CH3-CH). IR (neat) max/cm -1 = 3296, 2983, 2937, 2818, 1702, 1650, 1529, 1466, 1454 eq. = 20 L) and acetic acid (0.825 M, 1.1 = 10 L) were prepared. Aliquots (0.55, 1.1, 2.2 eq.) of the solution of Zn(ClO4)2.6H2O were added to the NMR tube to monitor the change in shift of the amide protons of 8 by 1 H-NMR. An aliquot of base (Bu4NOH, 1.1 eq.) was added and the change in helical screw-sense preference monitored by 13 C-NMR. This process was repeated with acid (AcOH, 1.1 eq.), then base, then acid again (see paper for NMR spectra regions of interest).
N3Aib4-L-AlaNH t Bu
To a stirred solution of N3Aib4OH (554 mg, 1.44 mmol), HOBt hydrate (265 mg, 1.73 mmol) and EDC hydrochloride (303 mg, 1.59 mmol) in anhydrous CH2Cl2 (14 mL) was added DIPEA (630 L, 3.61 mmol) and the mixture stirred at room temperature for 30 min. H-L-AlaNH t Bu (270 mg, 1.88 mmol; prepared by the quantitative hydrogenolysis of Z-L-AlaNH t Bu) was added in a single portion and the reaction stirred at room temperature for 2 d. The solution was diluted with CH2Cl2 (25 mL) and washed with KHSO4 (5%, 2 x 20 mL), NaHCO3 (sat., 2 x 20 mL) and brine (20 mL), then dried (MgSO4) and concentrated in vacuo. The crude residue was purified by flash column chromatography (1-5% MeOH in CH2Cl2) to give the title compound (696 mg, 95%) as a white solid. 2976, 2936, 2109, 1648, 1529, 1455, 1380, 1361, 1219 
Z-GlyAib4-L-AlaNH t Bu
To a stirred solution of Z-GlyOH (95 mg, 0.46 mmol) and NMM (50 mL, 0.46 mmol) in anhydrous THF (2 mL) at -20 °C was added IBCF (63 mL, 0.49 mmol) dropwise and the reaction stirred at -20 °C for 20 min. A solution of HAib4-L-AlaNH t Bu (147 mg, 0.30 mmol; prepared by the quantitative hydrogenolysis of N3Aib4-L-AlaNHtBu) and NMM (100 mL, 0.91 mmol) in THF (3 mL) was added, the cooling bath removed and the reaction stirred at room temperature for 2 d. The solution was diluted with EtOAc (20 mL) and washed with KHSO4 (5%, 2 x 15 mL), NaHCO3 (sat., 2 x 15 mL) and brine (20 mL), then dried (MgSO4) and concentrated in vacuo. The residue was purified by flash column chromatography (1-6% MeOH in CH2Cl2) to give the title compound (172 mg, 84%) as a white solid. -1 = 3304, 2983, 2937, 1651, 1525, 1455, 1384, 1362, 1267, 1227, 1169 . HRMS (ES + ; MeOH) Calc. for C33H54N7O8 = 676.4034, found 676.4039. Mp 124-126 °C.
[ ] = +28.9 (c 1.0, CHCl3). S10 General procedure A: synthesis of thiourea catalysts from non-commercially available isothiocyanates To a vigorously stirred biphasic mixture of primary amine and CaCO3 (3 equiv.) in CH2Cl2/H2O (1:1, 50 mL/mmol) at 0 °C was added thiophosgene dropwise and the mixture stirred at 0 °C for 2 h. The layers were separated and the aqueous layer extracted with CH2Cl2 (2 x 10 mL). The combined organics were washed with NaHCO3 (sat., 15 mL) and brine (15 mL), then dried (Na2SO4) and concentrated. The residue was purified by flash column chromatography and the corresponding isothiocyanate added as a solution in THF (10 mL/mmol) to a flame-dried RB flask charged with HAib4-L-AlaNH t Bu or HGlyAib4-L-AlaNH t Bu (1.0 equiv.) . The reaction was heated at reflux for 3-5 d, the solvents removed and the residue purified directly by flash column chromatography.
General procedure B: synthesis of thiourea catalysts from non-commercially available isothiocyanates
To a stirred solution of primary amine in anhydrous THF (10 mL/mmol) was added sequentially thiophosgene (1.2 equiv.) and DIPEA (2.4 equiv.) and the mixture stirred at room temperature for 2.5 h. The solvents were removed and the residue purified by flash column chromatography. The corresponding isothiocyanate was added as a solution in THF (20 mL/mmol) to a flame-dried RB flask charged with HAib4-L-AlaNH t Bu or HGlyAib4-L-AlaNH t Bu (1.0 equiv.). The reaction was heated at reflux for 3-5 d, the solvents removed and the residue purified directly by flash column chromatography.
General procedure C: synthesis of thiourea catalysts from commercially available isothiocyanates To a stirred solution of HAib4-L-AlaNH t Bu or HGlyAib4-L-AlaNH t Bu in anhydrous THF (20 mL/mmol) was added isothiocyanate (1.2 equiv.) and the reaction heated at reflux for 3-5 d. The solvents were removed and the residue purified directly by flash column chromatography.
1-(2-methyl-1-(piperidin-1-yl)propan-2-yl)thiourea-Aib4-L-AlaNH t Bu 9a
Prepared using general procedure A from 2-methyl-1-(piperidin-1-yl)propan-2-amine (31 mg, 0.20 mmol), CaCO3 (60 mg, 0.60 mmol) and thiophosgene (23 L, 0.30 mmol). Purification by flash column chromatography (Hexane:EtOAc; 50:50) gave 1-(2-isothiocyanato-2-methylpropyl)piperidine (22 mg, 0.11 mmol) as a yellow oil, which was added as a solution in THF (1.5 mL) to a flame-dried flask charged with H-Aib4-L-AlaNH t Bu (54 mg, 0.011 mmol). The reaction was heated at reflux for 5 d. Purification by flash column chromatography (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) CH2) , 58.7 (  C), 57.6 (  C), 57.3 (  C), 57.1 (  C), 56.9 (br, CH2), 51.2 (CMe3), 50.8 (  CH), 29.0 ((CH3)3), 27.7 (CH3), 27.6 (CH3), 27.5 (CH3), 27.3 (CH3), 25.9 (br, CH2), S11 24.6 (br, CH2), 23.6 (3 x CH3), 23.4 (CH3), 17.7 (CH3). IR (neat) max/cm -1 = 3306, 2976, 2933, 1651, 1526, 1454, 1381, 1361, 1295, 1223, 1169, 1105 . HRMS (ES + ; MeOH) Calc. for C33H63N8O5S = 683.4642, found 683.4622. Mp 141-143 °C. [ ] = −8.9 (c 1.0, MeOH).
1-(2-methyl-1-(piperidin-1-yl)propan-2-yl)thiourea-GlyAib4-L-AlaNH t Bu 9b
Prepared using general procedure B from 2-methyl-1-(piperidin-1-yl)propan-2-amine (13 mg, 0.080 mmol), thiophosgene (8.0 L, 0.096 mmol) and DIPEA (33 L, 0.19 mmol). Purification by flash column chromatography (Hexane:EtOAc, 50:50) gave 1-(2-isothiocyanato-2-methylpropyl)piperidine as a yellow oil (9.0 mg, 0.046 mmol), which was added as a solution in THF (1 mL 
Synthesis of 1-(2-methyl-2-(piperidin-1-yl)propyl)thiourea-Aib4-L-AlaNH t Bu 9c
Prepared using general procedure B from 2-methyl-2-(piperidin-1-yl)propan-1-amine (78 mg, 0.50 mmol), thiophosgene (46 L, 0.60 mmol) and DIPEA (209 L, 1.20 mmol). Purification by flash column chromatography (Hexane:EtOAc, 50:50) gave 1-(1-isothiocyanato-2-methylpropan-2yl)piperidine (81 mg, 0.41 mmol) as a yellow oil, a portion of which (22 mg, 0.10 mmol) was added as a solution in THF (1.5 mL) to a flame-dried flask charged with HAib4-L-AlaNH t Bu (48 mg, 0.11 mmol). The reaction was heated at reflux for 5 d. Purification by flash column chromatography (5-20% MeOH in CH2Cl2) gave the title compound (59 mg, 79%) as an off-white solid. 1 H-NMR (500 MHz, MeOD-d4) δH 8.13 (1H, br s), 7.90 (1H, s), 7.85 (1H, d, J = 7.0), 7.70 (1H, s), 7.07 (1H, s), 4.11 (1H, dq, J = 7.0), 3.68 (2H, br s), 2.70 (3H, br s), 1.72 (3H, br s), 1.66 (3H, s), 1.52 (3H, s), 1.51 (3H, s), 1.48 (3H, s), 1.44-1.40 (15H, m) 1.37 (9H, s), 1.21 (6H, br s); 2 x CH (piperidine) not observed due to line broadening. 13 C-NMR (125 MHz, MeOD) δC 182.3 (CS), 177.5 (CO), 177.4 (CO), 177.3 (CO), 174.9 (CO), 59.9 (br, CH2), 58.1 (2 x  C), 57.9 (2 x  C), 57.8 (C), 52.4 (CMe3), 52.3 (CH2), 51.9 (  CH), 29.0 ((CH3)3), 28.0 (CH3), 27.5 (CH3), 27.3 (CH3), 26.9 (CH3), 24.3 (CH3), 24.0 (CH3), 23.9 (CH3), 23.6 (CH3),
